For patients with clinically localized prostate cancer, radical prostatectomy and external-beam radiotherapy are equally effective, results of a single-center study suggest.
Dr. Patrick A. Kupelian, now of M.D. Anderson Cancer Center Orlando, and colleagues at the Cleveland Clinic determined biochemical relapse-free survival rates for 1054 men who underwent radical prostatectomy and 628 who underwent external-beam radiotherapy for localized prostate cancer.
Eight-year biochemical relapse-free survival rates for surgery and radiotherapy were similar, 72% and 70%, respectively, the team reports in the August 15th issue of the Journal of Clinical Oncology. “Intrinsic tumor characteristics seem to be more important than treatment modality in 8-year biochemical-free relapse rates after radiation or surgery,” they write.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!